This content is from: Home

Roche loses patent opposition in India

In another blow to multinational pharmaceutical companies in India, the Chennai Patent Office has invalidated a key patent owned by Swiss drug maker F Hoffmann La Roche, allowing generic competitors to enter the market

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial